Novavax, Inc. (NVAX)
12.82
+0.18
(+1.42%)
USD |
NASDAQ |
Oct 15, 16:00
12.82
0.00 (0.00%)
After-Hours: 04:42
Novavax Cash from Operations (TTM) : -36.90M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -36.90M |
| March 31, 2026 | -91.56M |
| December 31, 2025 | -244.64M |
| September 30, 2025 | -378.32M |
| June 30, 2025 | -630.94M |
| March 31, 2025 | -189.21M |
| December 31, 2024 | -87.26M |
| September 30, 2024 | -90.88M |
| June 30, 2024 | 14.28M |
| March 31, 2024 | -471.93M |
| December 31, 2023 | -717.56M |
| September 30, 2023 | -658.59M |
| June 30, 2023 | -657.65M |
| March 31, 2023 | -656.61M |
| December 31, 2022 | -415.94M |
| September 30, 2022 | -640.53M |
| June 30, 2022 | -743.96M |
| March 31, 2022 | -428.65M |
| December 31, 2021 | 322.95M |
| September 30, 2021 | 536.79M |
| June 30, 2021 | 672.43M |
| March 31, 2021 | 643.65M |
| December 31, 2020 | -42.54M |
| September 30, 2020 | 62.28M |
| June 30, 2020 | 36.52M |
| Date | Value |
|---|---|
| March 31, 2020 | -109.13M |
| December 31, 2019 | -136.62M |
| September 30, 2019 | -158.15M |
| June 30, 2019 | -159.40M |
| March 31, 2019 | -169.36M |
| December 31, 2018 | -184.82M |
| September 30, 2018 | -175.10M |
| June 30, 2018 | -185.76M |
| March 31, 2018 | -158.19M |
| December 31, 2017 | -136.62M |
| September 30, 2017 | -160.65M |
| June 30, 2017 | -181.44M |
| March 31, 2017 | -232.16M |
| December 31, 2016 | -258.77M |
| September 30, 2016 | -217.45M |
| June 30, 2016 | -181.01M |
| March 31, 2016 | -130.21M |
| December 31, 2015 | -89.89M |
| September 30, 2015 | -91.11M |
| June 30, 2015 | -78.66M |
| March 31, 2015 | -77.41M |
| December 31, 2014 | -68.13M |
| September 30, 2014 | -59.63M |
| June 30, 2014 | -58.31M |
| March 31, 2014 | -55.86M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Moderna, Inc. | -1.073B |
| Merck & Co., Inc. | 19.97B |
| Pfizer Inc. | 13.40B |
| Agenus, Inc. | -98.50M |
| Editas Medicine, Inc. | -119.86M |